Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cytomegalovirus Disease

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

Cirrhosis I: Introduction

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

Cirrhosis II: Pathophysiology

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An international study on emerging arboviral infections and blood safety.

Transfusion·2026

Same author

The LIFE study: a cross-sectional study protocol for LIfestyle risk Factors for chronic disease across the stagEs of reproductive ageing.

BMJ open·2026

Same author

Genetic diversity in RHD and RHCE genes among a selected Kenyan blood donor population.

Transfusion·2026

Same author

Assessing dengue outbreak risks to blood donation safety, beyond significant outbreak areas in Australia.

Vox sanguinis·2026

Same author

A congress report of the new Emerging Pathogens and Parasitology Subgroup within the ISBT Working Party on Transfusion-Transmitted Infectious Diseases.

Vox sanguinis·2025

Same author

Seroprevalence of Antibodies Against Legionella Species in Northeastern Australian Blood Donors, 2016 and 2023.

The Journal of infectious diseases·2025

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Understanding occult hepatitis C infection.

Timothy An^1,2, Melinda Dean^1,3, Robert Flower¹

¹Research and Development, Australia Red Cross Lifeblood, Kelvin Grove, Queensland, Australia.

|January 18, 2021

Summary

Occult hepatitis C infection (OCI) is a distinct form of hepatitis C virus (HCV) infection. Further research is needed to fully understand its clinical course and transmission.

More Related Videos

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Experiment Videos

Last Updated: Jun 14, 2026

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Area of Science:

Hepatology
Virology
Infectious Diseases

Background:

Occult hepatitis C infection (OCI) is defined by the presence of hepatitis C virus (HCV) RNA in hepatocytes or PBMCs, with serum RNA being undetectable.
OCI represents a unique clinical presentation of HCV infection, distinct from chronic hepatitis C.

Purpose of the Study:

To review and synthesize current knowledge on OCI, encompassing its epidemiology, transmission, infection patterns, progression, and treatment.
To identify knowledge gaps and suggest future research directions for OCI.

Main Methods:

A comprehensive literature review was performed.
Articles were selected based on their characterization of OCI's disease aspects.

Main Results:

OCI patients exhibit less severe inflammatory and cirrhotic changes compared to chronic hepatitis C patients.
OCI is parenterally transmissible, but its duration and outcomes remain largely unknown.
OCI is frequently observed in individuals with prior hepatitis C, those on hemodialysis, and even in healthy populations.

Conclusions:

Current understanding of OCI's epidemiology and clinical course is limited.
Standardized detection methods, surveillance, and transmission studies are crucial for advancing OCI research.
Further investigation is required to elucidate the full clinical implications of OCI.